NCT01615848

Brief Summary

Polycystic ovary syndrome (PCOS) affects 5-10% of women and is the most common endocrine syndrome.PCOS is associated with infertility, risk for obesity and type 2 diabetes. The elevated insulin characteristic of PCOS is likely to play a major role in its symptoms. restricted calorie High protein diet and mediterranean diet may improve insulin sensitivity and therefore lower androgen production in women with pcos women.the purpose of this study is to determine which diet is more effective in improving metabolic and reproductive outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 11, 2012

Completed
10 months until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

February 20, 2013

Status Verified

February 1, 2013

Enrollment Period

7 months

First QC Date

June 7, 2012

Last Update Submit

February 19, 2013

Conditions

Keywords

polycystic Ovary syndrome (PCOS)dietmediterranean diethigh protein diet

Outcome Measures

Primary Outcomes (1)

  • improvement in metabolic outcomes of women with pcos

    18 months

Secondary Outcomes (1)

  • improvement in clinical symptoms: acne, hirsutism and menstrual regularity

    18 months

Study Arms (2)

mediterranean diet restricted calorie

EXPERIMENTAL

1500 k/calories 47-51% carbohydrate 14-17% protein 33-36% fat: 7-7.6% saturated fat 22-30% monounsaturated \& polyunsaturated fat

Other: mediterranean diet restricted calorie

high protein diet, restricted calorie

EXPERIMENTAL

1500 k/calories 40 % carbohydrate 30% protein 30% fat

Other: high protein diet

Interventions

1500 k/cal 30% fat

mediterranean diet restricted calorie

50 pcos diagnosed women will be assigned to high protein diet for 18 month

high protein diet, restricted calorie

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Polycystic ovary syndrome

You may not qualify if:

  • Pregnancy
  • Lactation 6 month prior to study
  • Known hyperandrogenism
  • More then 5 kg weight loss 6 month prior to study
  • Imbalance pituitary hormones
  • Alcohol or drug abuse
  • Chronic disease - kidney/heart/diabetes/lung
  • Psychiatric disease
  • Drug use accept contraceptive pills

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clalit Health Services

Haifa, Israel, Israel

Location

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Diet, High-Protein

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Adam Geva, MD

    Clalit Health Services

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2012

First Posted

June 11, 2012

Study Start

April 1, 2013

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

February 20, 2013

Record last verified: 2013-02

Locations